Published in Anal Biochem on January 19, 2009
Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. Chem Biol (2009) 1.47
Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomib. Chem Biol (2011) 1.13
Identification of mutant firefly luciferases that efficiently utilize aminoluciferins. Chem Biol (2011) 1.10
Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication. J Biol Chem (2011) 1.06
TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther (2012) 1.01
Nature of pharmacophore influences active site specificity of proteasome inhibitors. J Biol Chem (2010) 0.94
LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites. Cell Biochem Biophys (2011) 0.94
Inhibitors of the immunoproteasome: current status and future directions. Curr Pharm Des (2013) 0.92
Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib. PLoS One (2013) 0.86
Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol. J Biol Chem (2010) 0.86
Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis. Cell Biochem Biophys (2013) 0.85
Discovery of novel proteasome inhibitors using a high-content cell-based screening system. PLoS One (2009) 0.83
UVA causes dual inactivation of cathepsin B and L underlying lysosomal dysfunction in human dermal fibroblasts. J Photochem Photobiol B (2013) 0.80
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol (2010) 0.80
Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion. Virol J (2014) 0.78
Proteasome inhibitors alter levels of intracellular peptides in HEK293T and SH-SY5Y cells. PLoS One (2014) 0.78
Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches. Oncotarget (2015) 0.76
Multicolor monitoring of the proteasome's catalytic signature. ACS Chem Biol (2014) 0.75
Proteolytic activities in cortex of apical parts of Vicia faba ssp. minor seedling roots during kinetin-induced programmed cell death. Protoplasma (2017) 0.75
Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol (2006) 1.40
A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal Biochem (2007) 1.15
In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics (2009) 1.10
N-Alkylated 6'-aminoluciferins are bioluminescent substrates for Ultra-Glo and QuantiLum luciferase: new potential scaffolds for bioluminescent assays. Biochemistry (2008) 1.07
Bioluminescent assays for ADMET. Expert Opin Drug Metab Toxicol (2008) 1.07
Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen (2005) 1.06
Update on in vitro cytotoxicity assays for drug development. Expert Opin Drug Discov (2008) 0.95
A bioluminescent assay for monoamine oxidase activity. Anal Biochem (2006) 0.94
Electrophilic aromatic substituted luciferins as bioluminescent probes for glutathione S-transferase assays. Chem Commun (Camb) (2006) 0.87
New bioluminogenic substrates for monoamine oxidase assays. J Am Chem Soc (2006) 0.86
Homogeneous, bioluminescent proteasome assays. Methods Mol Biol (2008) 0.79
Caspase activity assays. Methods Mol Biol (2008) 0.78
Multiplex caspase activity and cytotoxicity assays. Methods Mol Biol (2008) 0.77
"Multiplexed viability, cytotoxicity, and caspase activity assays". Methods Mol Biol (2015) 0.77
Self-immolative bioluminogenic quinone luciferins for NAD(P)H assays and reducing capacity-based cell viability assays. Chembiochem (2014) 0.76
A bioluminescent assay for the sensitive detection of proteases. Biotechniques (2011) 0.75
Homogeneous, bioluminescent proteasome assays. Methods Mol Biol (2015) 0.75
A bioluminescence assay for aldehyde dehydrogenase activity. Anal Biochem (2012) 0.75